Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
暂无分享,去创建一个
[1] R. Langer,et al. Improved immunogenicity of a core-coated tetanus toxoid delivery system. , 1999, Vaccine.
[2] K. Johnston,et al. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent. , 1999, Journal of pharmaceutical sciences.
[3] S. Schwendeman,et al. Influence of basic salts on stability and release of proteins in injectable poly(lactide-co-glycolide) delivery devices , 1999 .
[4] T. Burke,et al. The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.
[5] B. Gander,et al. Quality improvement of spray-dried, protein-loaded D,L-PLA microspheres by appropriate polymer solvent selection. , 1995, Journal of microencapsulation.
[6] B. Gander,et al. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] R. Mehta,et al. Adsorption of peptides to poly(D,L-lactide-co-glycolide): 1. Effect of physical factors on the adsorption , 1996 .
[8] A. Klibanov,et al. Can conformational changes be responsible for solvent and excipient effects on the catalytic behavior of subtilisin Carlsberg in organic solvents? , 1997, Biotechnology and bioengineering.
[9] D. Pettit,et al. Biodegradable polymers for protein and peptide drug delivery. , 1995, Bioconjugate chemistry.
[10] C. Jones,et al. Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. , 1996, Vaccine.
[11] R. Gupta,et al. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. , 1994, Vaccine.
[12] T. Uchida,et al. Microencapsulation of Hepatitis B Core Antigen for Vaccine Preparation , 1998, Pharmaceutical Research.
[13] P. G. Shao,et al. Porcine Insulin Biodegradable Polyester Microspheres: Stability and In Vitro Release Characteristics , 2000, Pharmaceutical development and technology.
[14] B. Gander,et al. Improving Stability and Release Kinetics of Microencapsulated Tetanus Toxoid by Co-Encapsulation of Additives , 1998, Pharmaceutical Research.
[15] P. Riesz,et al. Free radical formation induced by ultrasound and its biological implications. , 1992, Free radical biology & medicine.
[16] H. Sah. Protein behavior at the water/methylene chloride interface. , 1999, Journal of pharmaceutical sciences.
[17] J L Cleland,et al. Development of a single-shot subunit vaccine for HIV-1. , 1997, AIDS research and human retroviruses.
[18] R. Tilton,et al. Adsorption of serum albumin to thin films of poly(lactide-co-glycolide). , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[19] M. Alonso,et al. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[20] María J. Alonso,et al. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .
[21] E. Topp,et al. Solid-state chemical stability of proteins and peptides. , 1999, Journal of pharmaceutical sciences.
[22] T. Park,et al. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. , 1995, PDA journal of pharmaceutical science and technology.
[23] J. Cleland. Solvent Evaporation Processes for the Production of Controlled Release Biodegradable Microsphere Formulations for Therapeutics and Vaccines , 1998, Biotechnology progress.
[24] R. K. Rana,et al. Release of Human Serum Albumin from Poly(lactide-co-glycolide) Microspheres , 1990, Pharmaceutical Research.
[25] A. Domb,et al. Chemical Interactions Between Drugs Containing Reactive Amines with Hydrolyzable Insoluble Biopolymers in Aqueous Solutions , 1994, Pharmaceutical Research.
[26] T. Park,et al. Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles , 1996 .
[27] T. Park,et al. A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[28] J. Pedraz,et al. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems. , 1997, Journal of microencapsulation.
[29] Brooks M. Boyd,et al. The Stability of Recombinant Human Growth Hormone in Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 1997, Pharmaceutical Research.
[30] T. Park,et al. Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. , 1999, Biotechnology and bioengineering.
[31] Michael J. Pikal,et al. Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.
[32] K. N. Dollman,et al. - 1 , 1743 .
[33] A. Coombes,et al. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[34] A. Klibanov,et al. Solid-phase aggregation of proteins under pharmaceutically relevant conditions. , 1994, Journal of pharmaceutical sciences.
[35] A. Klibanov,et al. Structure of lysozyme dissolved in neat organic solvents as assessed by NMR and CD spectroscopies. , 1999, Biotechnology and bioengineering.
[36] C Vigneron,et al. Preparation and characterization of protein C-loaded PLA nanoparticles. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[37] J. Cleland,et al. The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres , 1997, Pharmaceutical Research.
[38] M A Tracy,et al. Development and Scale‐up of a Microsphere Protein Delivery System , 1998, Biotechnology progress.
[39] J. Carpenter,et al. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. , 1999, Journal of pharmaceutical sciences.
[40] Gerhard Winter,et al. Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients , 1997 .
[41] C. M. Agrawal,et al. Technique to control pH in vicinity of biodegrading PLA-PGA implants. , 1997, Journal of biomedical materials research.
[42] T. Park,et al. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. , 1998, Journal of microencapsulation.
[43] J. Cleland,et al. Factors affecting the in vitro release of recombinant human interferon‐γ (rhIFN‐γ) from PLGA microspheres , 1997 .
[44] Brooks M. Boyd,et al. Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect , 1997 .
[45] Alexander M. Klibanov,et al. On Protein Denaturation in Aqueous−Organic Mixtures but Not in Pure Organic Solvents , 1996 .
[46] K. Griebenow,et al. Structure‐guided Encapsulation of Bovine Serum Albumin in Poly(DL‐lactic‐co‐glycolic) Acid , 1998 .
[47] M. Morlock,et al. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[48] J. Benoit,et al. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[49] M Morlock,et al. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[50] Smadar Cohen,et al. Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy , 1997 .
[51] M. Alonso,et al. New strategies for the microencapsulation of tetanus vaccine. , 1998, Journal of microencapsulation.
[52] A. Jones,et al. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. , 1996, Pharmaceutical research.
[53] R. Mashelkar,et al. Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[54] T. Kissel,et al. Monitoring Microviscosity and Microacidity of the Albumin Microenvironment Inside Degrading Microparticles from Poly(lactide-co-glycolide) (PLG) or ABA-triblock Polymers Containing Hydrophobic Poly(lactide-co-glycolide) A Blocks and Hydrophilic Poly(ethyleneoxide) B Blocks , 1998, Pharmaceutical Research.
[55] R. Heeren,et al. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[56] P. G. Shao,et al. Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. , 1999, Pharmaceutical development and technology.
[57] Tae Gwan Park,et al. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres , 1995 .
[58] B. Gander,et al. Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability. , 1998, Biochimica et biophysica acta.
[59] M. Alonso,et al. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. , 1999, International journal of pharmaceutics.
[60] S. Schwendeman,et al. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.
[61] X. Wu,et al. A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) microspheres using agarose hydrogel , 1998 .
[62] J. Cleland,et al. Stable Formulations of Recombinant Human Growth Hormone and Interferon-γ for Microencapsulation in Biodegradable Mircospheres , 1996, Pharmaceutical Research.
[63] R. Jerome,et al. Polylactide Microparticles Prepared by Double Emulsion-Evaporation: II. Effect of the Poly(Lactide-co-Glycolide) Composition on the Stability of the Primary and Secondary Emulsions , 1995 .
[64] K. Suslick,et al. The sonochemical hot spot , 1987 .
[65] M. Schimpf,et al. Bioerodible polymers for delivery of macromolecules , 1990 .
[66] P. Steerenberg,et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. , 2010, Annals of the rheumatic diseases.
[67] H. Sah. A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres. , 1997, Journal of pharmaceutical sciences.
[68] K. Mäder,et al. pH and Osmotic Pressure Inside Biodegradable Microspheres During Erosion1 , 1999, Pharmaceutical Research.
[69] A. Shahzamani,et al. A month–long effect from a single injection of microencapsulated human growth hormone , 1996, Nature Medicine.
[70] R. Mehta,et al. Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption , 1996 .
[71] S. Schwendeman,et al. Stabilization of bovine serum albumin encapsulated in injectable poly(lactide-co-glycolide) millicylinders) , 1998 .
[72] T. Kissel,et al. Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres. , 1999, Journal of microencapsulation.
[73] A. Klibanov,et al. FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[74] P. Morrissey,et al. Characterization of Poly(glycolide-co-D,L-lactide)/Poly(D,L-lactide) Microspheres for Controlled Release of GM-CSF , 1997, Pharmaceutical Research.
[75] H. Sah. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. , 1999, PDA journal of pharmaceutical science and technology.
[76] J. Park,et al. Double-walled microparticles for single shot vaccine , 1997 .
[77] J. Mcginity,et al. Selection of the solvent system for the preparation of poly(d,l-lactic-co-glycolic acid) microspheres containing tumor necrosis factor-alpha (TNF-α) , 1998 .
[78] J L Cleland,et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.
[79] S. Sharif,et al. A comparison of alternative methods for the determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles , 1995 .
[80] W Wang,et al. Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.
[81] J. Pedraz,et al. Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis , 1998 .
[82] J. Benoit,et al. Why Does PEG 400 Co-Encapsulation Improve NGF Stability and Release from PLGA Biodegradable Microspheres? , 1999, Pharmaceutical Research.
[83] M. Manning,et al. Controlled release of ionic compounds from poly (l-lactide) microspheres produced by precipitation with a compressed antisolvent , 1997 .
[84] H. Sah,et al. The influence of biodegradable microcapsule formulations on the controlled release of a protein , 1994 .
[85] H. Sah. Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[86] Chung C. Hsu,et al. On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer. , 1999, Journal of pharmaceutical sciences.
[87] D. Rose. PROTEIN STABILITY PROBLEMS. , 1965, Journal of dairy science.